Alnylam Pharmaceuticals I... (ALNY)

AI Score

Unlock

241.97

5.22 (2.20%)

At close: Apr 23, 2025, 3:59 PM

241.00

-0.40%

Pre-market: Apr 24, 2025, 08:34 AM EDT

Alnylam Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	127.13M	812.69M	866.39M	819.98M	496.58M	547.18M	420.15M	645.36M	193.62M
Short-Term Investments	1.73B	1.63B	1.33B	1.62B	1.38B	988.98M	664.01M	1.05B	433.18M
Long-Term Investments	n/a	n/a	-2.56B	40.89M	40.73M	14.82M	44.83M	30M	9M
Other Long-Term Assets	133.9M	-576.39M	115.48M	n/a	500M	n/a	n/a	n/a	150M
Receivables	405.31M	327.79M	237.96M	198.57M	102.41M	43.01M	18.76M	34M	23.33M
Inventory	78.51M	89.15M	128.96M	122.7M	92.3M	56.35M	24.07M	1.00	1.00
Other Current Assets	116.96M	126.38M	132.92M	n/a	562.77M	n/a	n/a	n/a	n/a
Total Current Assets	3.3B	2.98B	2.69B	2.87B	2.16B	1.73B	1.21B	1.78B	989.24M
Property-Plant & Equipment	693.93M	725.79M	738.63M	733.63M	706.51M	646.38M	320.66M	181.9M	114.57M
Goodwill & Intangibles	n/a	697.78M	264.56M	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	944.7M	847.18M	854.11M	774.52M	1.25B	661.2M	365.48M	211.9M	273.57M
Total Assets	4.24B	3.83B	3.55B	3.64B	3.41B	2.4B	1.57B	1.99B	1.26B
Account Payables	88.42M	55.52M	98.09M	73.43M	51.97M	49.88M	59.71M	28.36M	54.47M
Deferred Revenue	55.48M	102.75M	42.1M	301.84M	352.3M	396.2M	3.95M	84.78M	82.93M
Short-Term Debt	n/a	54.99M	40.29M	37.08M	13.32M	n/a	n/a	n/a	n/a
Other Current Liabilities	327.42M	590.84M	414.77M	301.59M	258.48M	128.9M	78.99M	40.37M	30M
Total Current Liabilities	1.19B	967.79M	767.91M	1.19B	1.13B	956.44M	242.84M	198.3M	192.59M
Long-Term Debt	n/a	2.34B	2.27B	1.83B	191.28M	276.13M	30M	30M	150M
Other Long-Term Liabilities	2.99B	308.44M	212.58M	98.96M	1.1B	-266.81M	62.88M	10.97M	11.5M
Total Long-Term Liabilities	2.99B	3.08B	2.94B	1.86B	1.26B	603.85M	30M	30M	150M
Total Liabilities	4.17B	4.05B	3.7B	3.06B	2.39B	956.44M	272.84M	228.3M	342.59M
Total Debt	1.3B	2.68B	1.32B	997.59M	521.19M	303.82M	30M	30M	150M
Common Stock	1.29M	1.26M	1.24M	1.2M	1.16M	1.12M	1.01M	997K	859K
Retained Earnings	n/a	-7.01B	-6.57B	-5.44B	-4.59B	-3.73B	-2.84B	-2.15B	-1.66B
Comprehensive Income	n/a	-23.38M	-44.65M	-33.26M	-43.62M	-36.52M	-33.21M	-34.43M	-33.44M
Shareholders Equity	67.09M	-220.64M	-158.22M	588.2M	1.02B	1.44B	1.3B	1.77B	920.22M
Total Investments	1.73B	1.63B	1.33B	1.62B	1.38B	1B	664.01M	1.06B	757.98M